From the Frontline of COVID-19: Clinician Perspectives on Anticoagulation

We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.